Trial intelligence / Profile preview

Bioidentical Hormones vs PremPro in Early Menopause

NCT00302731Phase 2Terminated

Start
Feb 2006
Primary completion
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of estradiol, estriol and progesterone in menopause (4 arms). Primary endpoints: Change in Total Cholesterol at 12 months, Endometrial Measurement at 12 months and 1 more. Started Feb 2006; status: terminated.

02

Drugs

estradiolestriolprogesterone
03

Conditions

menopause

Beyond the preview

Go deeper on NCT00302731.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00302731.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call